Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. “iSpecimen continues to prioritize expanding its proprietary network and platform to ensure that researchers all over the world can easily obtain invaluable biospecimen samples necessary to propel their work forward.” Christopher Ianelli, M.D., Ph.D., iSpecimen Founder and CEO. “Adding Acutis to the iSpecimen Marketplace ecosystem enables the platform to become even more of a full-service, one-stop-shop for researchers looking to find highly sought-after samples and genetic information for their medical research,” added Dr. “Furthermore, our investment in personnel, technology and other essential resources allows us to provide high-quality, whole genome sequencing to iSpecimen for COVID-19 remnants, tumor samples, and other biospecimens of interest.” “This important initiative between Acutis and iSpecimen highlights our ongoing efforts to advance research in the areas of oncology and COVID-19 today,” said Jibreel Sarij, Acutis CEO. By offering sequencing services for specimens procured on iSpecimen’s platform, researchers can now identify desired samples and receive corresponding sequencing data from a single source instead of vetting and contracting with external sequencing service provider partners. Through the Acutis relationship, iSpecimen will now offer sequencing services to its research community that can help researchers better understand genetic mutations and their impact on diseases such as COVID-19 and cancer.Ĭancer and COVID-19 are currently the second and third leading causes of death in the U.S., respectively. As such, biospecimen samples for these diseases, along with corresponding sequencing data, remain in high demand among researchers who are working on the development of novel diagnostics and therapeutics that could lead to lifesaving medical interventions. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global online biospecimen marketplace that enables life scientists to search across a federated network of healthcare providers for biospecimens needed for medical research, today announced that it added Acutis Diagnostics (“Acutis”), a clinical diagnostics laboratory, to its platform as a laboratory services provider. John T.LEXINGTON, Mass., Ap(GLOBE NEWSWIRE) - iSpecimen Inc. Lab CodeĪmerican Health Associates Laboratory SouthĪurora Diagnostics GPA Laboratories / Aurora DiagnĪurora Diagnostics, LMC Pathology Servicesīernhardt Laboratories - Aurora DiagnosticsĬedar Ridge Behavioral Health Services LabĬombined Physicians Lab (Integrated Bioscience)Ĭompliance Advantaage Laboratories (CAL) LLCĬonexus Laboratories (Anne Arundel Medical Center)Ĭunningham Pathology / Aurora Diagnosticsĭiagnostic Laboratory and Radiology-Tridentĭiagnostic Laboratory Services, Inc.-HawaiiĮast Side Clinical Laboratory - Sonic Healthcare In order to use the services of a laboratory which is not on LabSoft's Preferred Laboratories List, please submit one Connection Request Form for every lab you want to collaborate with and LabSoft will contact them to request a partnership. See the list of their preferred laboratories below. They already have the LabSoft software installed to enable order processing on the fly. These laboratories are ready to offer their services as soon as you enroll into eLabs. Our eLabs partner LabSoft has integrated with over 400 laboratories across the US.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |